Effectiveness of Repeated Administration of Energy Drinks Based on Cognitively Subjective and Objective Indicators
-A double‐blind, randomized clinical trial on healthy young adults-
Japanese Journal of Pharmaceutical Health Care and Sciences (Vol.36 , No.12,December 2010)
[ Regular Articles ]
Effectiveness of Repeated Administration of Energy Drinks Based on Cognitively Subjective and Objective Indicators
-A double‐blind, randomized clinical trial on healthy young adults-
H. Itoh, M. Isawa, T. Nishimura, M. Tomi, H. Shimada, M. Mochizuki, E. Nakashima
847
In vitro Evaluation of Anticancer Effects of FOLFIRI and mFOLFOX6 Chemotherapy Regimens and Their Effects on EGFR Expression
E. Hayashi, M. Kobayashi, N. Takahashi, T. Hirano,S. Itagaki, T. Yamada, K. Iseki
855
[ Notes ]
Survey on Benzodiazepine Prescriptions
M. Nakajima, M. Homma, T. Igarashi, Y. Kambayashi,M. Ohara, I. Nagasawa, Y. Kohda
863
Involvement of Pharmacists in Self‐injection Treatment with Interferon for Patients with Multiple Sclerosis
J. Fujii, T. Hirano, Y. Maeda, T. Hirahara, S. Yamashita,S. Honda, M. Uchino, H. Saito
868
Amount of Amlodipine Besilate Released from Tablets(Originator and Generic Drugs) in Simple Suspension Method
F. Ogata, N. Kawasaki, T. Hayashi, S. Nishiura,H. Matsuoka, S. Tachibana, K. Kakehi
874
Effectiveness of Interventions by Pharmacists in Ensuring Safety and Efficacy of Outpatient Chemotherapy Prescriptions
K. Makihara, M. Ohta, H. Ueno, I. Hama
880
Survey of Needle‐stick Injuries in Pharmacies Sustained in Collection of Medical Waste from Patient Homes and Its Disposal
Y. Tayama, K. Sugihara, K. Miyake, K. Nishimura, T. Nakajima,N. Murakami, M. Toyomi, S. Morita, S. Ohta
887
Evaluation of Use of Six Types of Simple Blood Glucose Meter
M. Abe, M. Kageyama, A. Katagiri, K. Nagai,E. Hara, T. Yamada, T. Asakura
893
Mechanisms Responsible for Different Rates of Uptake of Mizoribine and Ribavirin by Human Epithelial LS180 Cells
K. Ishida, M. Takaai, A. Yotsutani, A. Yokota, T. Sakamoto,M. Taguchi, H. Matsukura, T. Miyawaki, Y. Hashimoto
900
Compatibility Assessment of Closed‐system Device “PhaSeal® SOLUS” and Antineoplastic‐agent Vials